Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 6Brain Neoplasms 3Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Pain 1Mental Disorders 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Depression 1Central Nervous System Neoplasms 1Caregiver Burden 1Breast Neoplasms 1

Interventions

Therapeutics 6Escitalopram 4Yoga 3Surveys and Questionnaires 3Sugars 2Psychiatric Rehabilitation 2Psilocybin 2Ketamine 2Vorinostat 1Ultraviolet Therapy 1Typhoid-Paratyphoid Vaccines 1Therapeutic Touch 1Temozolomide 1Self-Help Groups 1Selective Serotonin Reuptake Inhibitors 1Saline Solution 1Psychosocial Intervention 1Niacin 1Minocycline 1Methylphenidate 1Melatonin 1Massage 1Mass Screening 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Interleukin-2 1Infliximab 1Imagery, Psychotherapy 1Fatty Acids, Omega-3 1Exercise Test 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Depression × Methylphenidate × Clear all
NCT00129467 2015-04-24

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

VA Office of Research and Development

Phase NA Completed
47 enrolled 13 charts

Caregiver Burden, Mental Disorders, Depression, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡